Inventor · disambiguated record
Sean Wesley Smith
Also filed as: SMITH SEAN · SMITH SEAN W · SMITH SEAN WESLEY
10 granted patents·17 pending applications·32 citations·filing 2010–2023
86Inventor score
Files withSILVERBACK THERAPEUTICS INC18BRANSTROM ARTHUR2CELLERANT THERAPEUTICS INC2FIREFLY BIO INC2MACCOSS MALCOLM1
Top patents by PatentIndex Score
27 records- 0194US10428045B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Granted Oct 1, 2019·7 cites·39 claims
- 0293US10519131B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·6 cites·13 claims
- 0393US10442790B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Granted Oct 15, 2019·5 cites·41 claims
- 0490US10239862B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Granted Mar 26, 2019·7 cites·21 claims
- 0576US9409905B2Antibacterial compounds and methods for useBRANSTROM ARTHUR·Filed 2012·Granted Aug 9, 2016·4 cites·21 claims
- 0671US10350218B2Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-benzo[e]indole (CBI) dimersCELLERANT THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·1 cites·11 claims
- 0770US2020031798A1Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0867US8735414B2Indole derivatives and methods for antiviral treatmentMACCOSS MALCOLM·Filed 2010·Granted May 27, 2014·2 cites·15 claims
- 0965US11541126B1Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·0 cites·30 claims
- 1063US2024218011A1Glucocorticoid receptor agonists and conjugates thereofFIREFLY BIO INC·Filed 2023·Application pending·0 cites
- 1163US2023062712A1Anti-asgr1 antibody conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1262US2024067640A1Phenyl maleimide linker agentsFIREFLY BIO INC·Filed 2023·Application pending·0 cites
- 1353US2022048895A1Substituted benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1453US2022362396A1Amino-pyrazinecarboxamide compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1550US2021154188A1Alk5 inhibitors, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1650US2020061079A1Isoquinolidinobenzodiazepine (iqb)-1(chloromethyl)-2,3-dihydro-1h-benzo[e]indole (cbi) dimersCELLERANT THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1750US2020113912A1Methods and Compositions for the Treatment of Disease with Immune Stimulatory ConjugatesSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1850US2022169660A1Cyclic amino-pyrazinecarboxamide compounds and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1950US2021130473A1TGFßR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOFSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2050US2021154317A1Compositions and methods for the treatment of viral infectionsSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2150US2021139477A1Alk5 inhibitors, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2249US2021077632A1Formulations of Benzazepine Conjugates and Uses ThereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2346US2022323596A1Antibody conjugates of toll-like receptor agonistsSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2443US2015038438A1Antibacterial compounds and methods for usePTC THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2541US9650395B2Antibacterial compounds and methods for useBRANSTROM ARTHUR·Filed 2012·Granted May 16, 2017·0 cites·19 claims
- 2641US2019336615A1Tumor targeting conjugates and methods of use thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2735US10654873B2Cytotoxic agents and conjugates thereofPOLYTHERICS LTD·Filed 2017·Granted May 19, 2020·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Sean Wesley Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →